Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients

Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients

OBJECTIVES:. To evaluate safety and clinical outcomes of extracorporeal immunomodulation treatment with a selective cytopheretic device (SCD) in COVID-19 ICU patients with multiple organ failure. DESIGN:. Two-center, prospective, single-arm treatment clinical trial. SETTING:. ICUs at two academic me...

Full description

Bibliographic Details
Main Authors: Lenar T. Yessayan, MD, MS, Javier A. Neyra, MD, MS, Angela J. Westover, BS, Balazs Szamosfalvi, MD, H. David Humes, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-05-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000694

Internet

http://journals.lww.com/10.1097/CCE.0000000000000694

Similar Items